Poorly differentiated thyroid carcinomas: Application of the Turin proposal provides prognostic results similar to those from the assessment of high-grade features

Histopathology

Volumn 64, Issue 2, 2014, Pages 263-273

  Gnemmi, Viviane ^a,b   Renaud, Florence ^a,b   Do Cao, Christine ^a   Salleron, Julia ^a   Lion, Georges ^a   Wemeau, Jean Louis ^a,b   Copin, Marie Christine ^a,b   Carnaille, Bruno ^a,b   Leteurtre, Emmanuelle ^a,b   Pattou, François ^a,b   Aubert, Sébastien ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

Author keywords

Histological labelling; Ki67 antigen; Papillary thyroid carcinoma; Thyroid carcinoma

Indexed keywords

IODINE 131; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CELL NUCLEUS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MEDICAL INFORMATION; METHODOLOGY; MITOSIS; OUTCOME ASSESSMENT; POORLY DIFFERENTIATED THYROID CANCER; PRIORITY JOURNAL; THYROID CARCINOMA;

HISTOLOGICAL LABELLING; KI67 ANTIGEN; PAPILLARY THYROID CARCINOMA; THYROID CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOSIS; NECROSIS; NEOPLASM GRADING; PROGNOSIS; THYROID GLAND; THYROID NEOPLASMS;

EID: 84890246633     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12246     Document Type: Article

References (34)

1. Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 1983; 52; 1849-1855.
2. Carcangiu ML, Zampi G, Rosai J. Poorly differentiated ('insular') thyroid carcinoma. A reinterpretation of Langhans' 'wuchernde Struma'. Am. J. Surg. Pathol. 1984; 8; 655-668.
3. Tallini G. Poorly differentiated thyroid carcinoma. Are we there yet? Endocr. Pathol. 2011; 22; 190-194.
4. Sobrinho-Simões M, Albores-Saavedra J, Tallini G et al. Poorly differentiated thyroid carcinoma. In DeLellis RA, Lloyd RV, Heitz PU eds. WHO classification of tumors, pathology and genetics - tumors of endocrine organs. Lyon: IARC Press, 2004; 73-76.
5. Gill A, Delbridge L. Prevalence and prognostic significance of poor differentiation and tall cell variant in papillary carcinoma in Japan. World J. Surg. 2008; 32; 1544-1545.
6. Volante M, Collini P, Nikiforov YE et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am. J. Surg. Pathol. 2007; 31; 1256-1564.
7. Asioli S, Erickson LA, Righi A et al. Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression. Mod. Pathol. 2010; 23; 1269-1278.
8. Dettmer M, Schmitt A, Steinert H et al. Poorly differentiated oncocytic thyroid carcinoma. Diagnostic implications and outcome. Histopathology 2012; 7; 1045-1051.
9. Hiltzik D, Carlson DL, Tuttle RM et al. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer 2006; 106; 1286-1295.
10. Sadow PM, Faquin WC. Poorly differentiated thyroid carcinoma: an incubating entity. Front. Endocrinol. 2012; 3; 77.
11. Dettmer M, Schmitt A, Steinert H et al. Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed? Am. J. Surg. Pathol. 2011; 35; 1866-1872.
12. Sobrinho-Simões M, Asa SL, Kroll TG et al. Follicular carcinoma. In DeLellis RA, Lloyd RV, Heitz PU eds. WHO classification of tumors, pathology and genetics - tumors of endocrine organs. Lyon: IARC Press, 2004; 67-72.
13. Nikiforov YE, Ohori NP. Follicular carcinoma. In Nikiforov YE, Biddinger PW, Thompson LDR eds. Diagnostic pathology and molecular genetics of the thyroid. A comprehensive guide for practising thyroid pathology. Philadelphia: Lippincott Williams & Wilkins, 2009; 132-159.
14. Ito Y, Hirokawa M, Fukushima M et al. Prevalence and prognostic significance of poor differentiation and tall cell variant in papillary carcinoma in Japan. World J. Surg. 2008; 32; 1535-1543.
15. Sobrinho-Simões M, Eloy C, Magalhães J et al. Follicular thyroid carcinoma. Mod. Pathol. 2011; 24(Suppl. 2); S10-S18.
16. Volante M, Cavallo GP, Papotti M. Prognostic factors of clinical interest in poorly differentiated carcinomas of the thyroid. Endocr. Pathol. 2004; 15; 313-317.
17. Papotti M, Botto Micca F, Favero A et al. A. Poorly differentiated thyroid carcinomas with primordial cell component. A group of aggressive lesions sharing insular, trabecular, and solid patterns. Am. J. Surg. Pathol. 1993; 17; 291-301.
18. Sanders EM, LiVolsi VA, Brierley J et al. An evidence-based review of poorly differentiated thyroid cancer. World J. Surg. 2007; 31; 934-945.
19. Jung TS, Kim TY, Kim KW et al. Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma. Endocr. J. 2007; 54; 265-274.
20. Lin JD, Chao TC, Hsueh C. Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas. Clin. Endocrinol. 2007; 66; 224-228.
21. Pulcrano M, Boukheris H, Talbot M et al. Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification. Thyroid 2007; 17; 639-646.
22. Lind P, Kohlfürst S. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer. Semin. Nucl. Med. 2006; 36; 194-205.
23. Franc B, de la Salmonière P, Lange F et al. Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma. Hum. Pathol. 2003; 34; 1092-1100.
24. Lloyd RV, Erickson LA, Casey MB et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am. J. Surg. Pathol. 2004; 28; 1336-1340.
25. Mete O, Asa SL. Pitfalls in the diagnosis of follicular epithelial proliferations of the thyroid. Adv. Anat. Pathol. 2012; 19; 363-373.
26. Nishida T, Katayama S, Tsujimoto M, Nakamura J, Matsuda H. Clinicopathological significance of poorly differentiated thyroid carcinoma. Am. J. Surg. Pathol. 1999; 23; 205-211.
27. Nikiforov YE, Erickson LA, Nikiforova MN et al. Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior. Am. J. Surg. Pathol. 2001; 25; 1478-1484.
28. Akslen LA, LiVolsi VA. Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma. Cancer 2000; 88; 1902-1908.
29. Sobrinho-Simões M. Hail to the histologic grading of papillary thyroid carcinoma? Cancer 2000; 88; 1766-1768.
30. Rivera M, Ricarte-Filho J, Patel S et al. Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular study. Hum. Pathol. 2010; 41; 172-180.
31. Tuttle RM, Tala H, Shah J et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid 2010; 20; 1341-1349.
32. Tallini G, Garcia-Rostan G, Herrero A et al. Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Am. J. Surg. Pathol. 1999; 23; 678-685.
33. Ito Y, Miyauchi A, Kakudo K et al. Prognostic significance of ki-67 labeling index in papillary thyroid carcinoma. World J. Surg. 2010; 34; 3015-3021.
34. Rindi G, Klöppel G, Couvelard A et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2007; 451; 757-762.